Abingdon Health Ltd. has purchased a 50.1% equity stake in fellow private diagnostics firm Molecular Vision Ltd. (Mar.)
Molecular Vision spun off from Imperial College London in 2001 and has created BioLED, a device that can simultaneously...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?